Literature DB >> 6613985

Diminished adherence of sickle erythrocytes to cultured vascular endothelium by piracetam.

R M Nalbandian, R L Henry, C L Burek, C A Diglio, A I Goldman, G W Taylor, W H Hoffman.   

Abstract

Erythrocytes from both normal and sickle cell donors were incubated on a bed of cultured rat vascular endothelial cells. Although the adherence of the erythrocytes to the endothelial cells was equivalent for both classes of donor, addition of 1.5 mM piracetam significantly decreased this adherence regardless of donor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6613985     DOI: 10.1002/ajh.2830150206

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.

Authors:  Pankaj Paliwal; Debabrata Dash; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Use of piracetam improves sickle cell deformability in vitro and in vivo.

Authors:  E K Gini; J Sonnet
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

3.  Piracetam Attenuates LPS-Induced Neuroinflammation and Cognitive Impairment in Rats.

Authors:  Alok Tripathi; Pankaj Paliwal; Sairam Krishnamurthy
Journal:  Cell Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.046

Review 4.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.